← All drugs Report issue

tacatuzumab tetraxetan

mAbexperimentalADC

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Mucin-1BINDING AGENT
MUC1 binding agent
- Mucin-1 (MUC1) ↗

Chemistry & pharmacology

Multi-specific: No
Payload: Tetraxetan

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL2109291 ↗

Also known as

afp-cide
afp-cide
hafp-31
hafp-31
tacatuzumab tetraxetan